The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 USD | +1.03% | +7.66% | -1.34% |
Apr. 30 | Transcript : Nautilus Biotechnology, Inc., Q1 2024 Earnings Call, Apr 30, 2024 | |
Apr. 30 | Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
The company’s management will webcast a corresponding conference call beginning at
About
With its corporate headquarters in
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Source:
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-1.34% | 366M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |